GlassScriptPhysician profile
Zaher Akkad
NPI 1952308454
$9,063.16
in general payments reported to CMS, 2019-2025
41 companies · $810 in 2025
The $810 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,836 · 2020: $486 · 2021: $1,080 · 2022: $523 · 2023: $1,866 · 2024: $1,462 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,137.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,904.39 | 2019-2025 | Assurity, Gallant, Aveir |
| Edwards Lifesciences Corporation | $1,528.42 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $774.47 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $658.74 | 2019-2025 | Lifevest |
| Medtronic, INC. | $483.47 | 2021-2024 | Micra, Abre |
| Atricure, INC. | $393.20 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $258.86 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $228.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $224.06 | 2022-2023 | |
| Boston Scientific Corporation | $198.02 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Heartflow, INC. | $194.25 | 2023-2024 | Ffrct |
| Abiomed | $181.77 | 2019-2021 | |
| Bardy Diagnostics, INC. | $180.00 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $173.99 | 2022-2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $158.75 | 2019-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $152.93 | 2019-2025 | |
| Biotronik INC. | $150.83 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.53 | 2020-2024 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $121.81 | 2023 | Arcalyst |
| Ge Healthcare | $117.51 | 2019-2020 | |
| Teleflex LLC | $91.61 | 2019 | |
| Cleerly, INC. | $89.84 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Sanofi-Aventis U.S. LLC | $73.49 | 2019-2021 | |
| Novo Nordisk INC | $65.19 | 2024-2025 | Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $57.00 | 2022 | |
| Amgen INC. | $55.65 | 2024-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $48.99 | 2019-2022 | |
| Biosense Webster, INC. | $37.86 | 2023 | Carto 3 |
| Chiesi USA, INC. | $36.00 | 2019 | |
| Philips North America LLC | $35.85 | 2022 | |
| Lilly USA, LLC | $34.54 | 2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $33.48 | 2020-2024 | Wainua |
| Kestra Medical Technology Services, INC. | $31.19 | 2022 | |
| Akcea Therapeutics, INC. | $27.40 | 2020 | |
| Daiichi Sankyo INC. | $19.65 | 2023 | Injectafer |
| Recor Medical INC | $19.44 | 2024 | Paradise Renal Denervation System |
| Actelion Pharmaceuticals US, INC. | $19.20 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $17.70 | 2019 | |
| Angiodynamics, INC. | $16.46 | 2021 | |
| Inari Medical, INC. | $15.87 | 2021 | |
| Infobionic, INC | $15.09 | 2024 | Mome Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaher Akkad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.